What happened
Berenberg lifted its Lam Research price target to $420, flagging wafer fab equipment spending rising toward $164B in 2026 and $205B in 2027. The stock traded up 7.01%.
Why it matters
The higher targets signal analysts still expect a multi-year semiconductor capex upcycle, which supports Lam's revenue outlook as a major wafer fab equipment supplier.
What to watch
Insider selling by the CEO and other executives in early September is a caveat, though they kept sizable residual holdings. Watch whether consensus targets hold in the high-$370s to mid-$380s.
WHO IT HITSThis news lands on active traders and shareholders in semiconductor equipment stocks, who are weighing Bank of America's bullish capex outlook against recent insider selling and valuation multiples near 47x P/E.
Summaries like this, in your inbox every morning.
Lam Research shares jumped 7.01% on Saturday, September 19, 2026, after Berenberg raised its price target to $420, citing wafer fab equipment spending rising toward $164B in 2026 and $205B in 2027. That call lands alongside mixed moves from other analysts: UBS and Mizuho trimmed targets but kept Buy/Outperform ratings, leaving consensus in Buy territory with average targets in the high-$370s to mid-$380s.
The company itself has been active on capital returns. Its board approved a 27% dividend hike to $0.33 per share, payable 2026/10/14 to holders of record on 2026/09/23. It also plans to invest over $3B in its global lab network, including a new Oregon facility that boosts cleanroom R&D capacity by more than 50% for advanced AI chips.
A caveat is that several insiders, including the CEO and other executives, sold shares in early September while maintaining sizable residual holdings. Whether the AI-driven capex outlook translates into sustained gains may hinge on whether equipment spending tracks the $164B and $205B figures Berenberg cites, and on how the market weighs that against the stock's valuation near 47x P/E.
For example, today's edition would include:
AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. Q&As are published on this page for other readers too.
Twist Bioscience agreed to supply antibody characterization data services to Eli Lilly's AI-driven TuneLab dru…
Citi forecasts HBM bit demand rising 62% to 75.2 billion gigabits in 2027 and another 69% to 127.0 billion gig…
Lam Research posted record fiscal 2026 results with higher margin targets and richer dividends
RTX says AI-enabled borescoping has cut overall engine inspection time by more than 30%, with report generatio…
In fiscal 2026, Aehr posted $50.0 million revenue (down 15.2%), a $7.1 million net loss, and negative $5.4 mil…
Yahoo Finance compared Nvidia and Micron and picked Micron as the better AI stock for 2027, citing Micron's ma…
